Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 722-731, November 2007

Prospective Evaluation of Beta-Blocker Use at the Time of Hospital Discharge as a Heart Failure Performance Measure: Results From OPTIMIZE-HF

  • Gregg C. Fonarow, MD

      Affiliations

    • Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California
    • Corresponding Author InformationReprint requests: Gregg C. Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Avenue, Room 47-123 CHS, Los Angeles, CA 90095-1679.
    • ,
  • William T. Abraham, MD, FACP, FACC,

      Affiliations

    • Division of Cardiology, The Ohio State University, Columbus, Ohio
    • ,
  • Nancy M. Albert, PhD, RN

      Affiliations

    • George M. and Linda H. Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Wendy Gattis Stough, PHARMD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, North Carolina, and Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, North Carolina
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Barry H. Greenberg, MD

      Affiliations

    • Department of Medicine, UCSD Medical Center, University of California, San Diego, California
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Jie Lena Sun, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas (Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas [current affiliation])
    • ,
  • James B. Young, MD

      Affiliations

    • Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • on behalf of the OPTIMIZE-HF Investigators and Coordinators

Received 22 January 2007; received in revised form 17 May 2007; accepted 20 June 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The OPTIMIZE-HF registry is registered: www.clinicaltrials.gov, study number NCT00344513. The OPTIMIZE-HF registry and this study were funded by GlaxoSmithKline, Philadelphia, Pennsylvania.

PII: S1071-9164(07)00942-6

doi:10.1016/j.cardfail.2007.06.727

Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 722-731, November 2007

Article Tools

* Image Usage & Resolution